6.97
Schlusskurs vom Vortag:
$7.20
Offen:
$7.14
24-Stunden-Volumen:
151.84K
Relative Volume:
0.48
Marktkapitalisierung:
$193.59M
Einnahmen:
$331.52M
Nettoeinkommen (Verlust:
$-52.69M
KGV:
-3.0978
EPS:
-2.25
Netto-Cashflow:
$-14.47M
1W Leistung:
-4.13%
1M Leistung:
-0.99%
6M Leistung:
-24.57%
1J Leistung:
-2.52%
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
859 WARD DRIVE, GOLETA, CA
Vergleichen Sie INGN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
INGN
Inogen Inc
|
6.97 | 193.59M | 331.52M | -52.69M | -14.47M | -2.25 |
![]()
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
2023-07-14 | Herabstufung | Needham | Buy → Hold |
2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
2021-12-09 | Hochstufung | Needham | Hold → Buy |
2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-07-23 | Herabstufung | Needham | Buy → Hold |
2020-05-06 | Bestätigt | Needham | Buy |
2019-11-06 | Hochstufung | Needham | Hold → Buy |
2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2019-08-08 | Herabstufung | Stifel | Buy → Hold |
2019-08-07 | Herabstufung | Needham | Buy → Hold |
2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-05-08 | Bestätigt | Needham | Strong Buy |
2019-02-27 | Bestätigt | Needham | Strong Buy |
2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
2018-11-07 | Bestätigt | Needham | Buy |
2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
2018-08-22 | Fortgesetzt | Stifel | Buy |
2018-08-08 | Bestätigt | Needham | Strong Buy |
2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
2018-05-01 | Bestätigt | Needham | Strong Buy |
2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Geode Capital Management LLC Cuts Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Russell Investments Group Ltd. Decreases Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - Defense World
Oxygen Therapy Market to Hit USD 47.6 Billion by 2031 | Growth Fueled by GE Healthcare & Inogen - openPR.com
Inogen Announces Third Quarter 2024 Financial Results - ADVFN
JPMorgan Chase & Co. Lowers Stock Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - MSN
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025 | INGN Stock News - GuruFocus
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025 - The Joplin Globe
American Century Companies Inc. Has $503,000 Stock Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Sei Investments Co. Takes Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (NASDAQ:INGN) Earns Hold Rating from Needham & Company LLC - Defense World
Inogen stock touches 52-week low at $6.4 amid market challenges - Investing.com Canada
Inogen stock touches 52-week low at $6.4 amid market challenges By Investing.com - Investing.com South Africa
Inogen at Needham Conference: Strategic Growth Amid Challenges - Investing.com
Inogen at Needham Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
(INGN) Technical Data - news.stocktradersdaily.com
Prudential Financial Inc. Grows Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (INGN) Down 11.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Favourable Signals For Inogen: Numerous Insiders Acquired Stock - Yahoo Finance
Inogen, Inc. (NASDAQ:INGN) Shares Bought by Bank of New York Mellon Corp - Defense World
Medical Oxygen Market to Continue Impressive Measured Growth - openPR.com
AlphaQuest LLC Takes Position in Inogen, Inc. (NASDAQ:INGN) - The AM Reporter
Inogen To Present at 24th Annual Needham Virtual Healthcare Conference - Sharewise
Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) versus Inogen (NASDAQ:INGN) Head to Head Contrast - Defense World
(INGN) On The My Stocks Page - news.stocktradersdaily.com
Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Why Investors Shouldn't Be Surprised By Inogen, Inc.'s (NASDAQ:INGN) 35% Share Price Plunge - Simply Wall St
Truist Financial Corp Has $104,000 Stake in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen CFO Michael Bourque buys $24,960 in company stock - Investing.com India
Inogen CEO Kevin Merrill buys $100k in stock By Investing.com - Investing.com Australia
Insider Buying: Smith Kevin Raymond Merrill Acquires Shares of I - GuruFocus.com
Insider Buying: Michael Bourque Acquires Shares of Inogen Inc (I - GuruFocus.com
Inogen Executives Make Bold Moves with Major Stock Purchases! - TipRanks
Inogen CEO Kevin Merrill buys $100k in stock - Investing.com India
Medical Oxygen Systems Market Is Booming Worldwide 2025-2032: Koninklijke Philips N.V, Inogen, Inc., BOC - EIN News
A Volatile Share Price Masks Some Of The Progress At Inogen (NASDAQ:INGN) - Seeking Alpha
Inogen (NASDAQ:INGN) Releases Quarterly Earnings Results - MarketBeat
Inogen’s (INGN) “Hold” Rating Reiterated at Needham & Company LLC - Defense World
Inogen's (INGN) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Inogen Inc SEC 10-K Report - TradingView
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.00 - Simply Wall St
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):